Clinical Trials Sponsored by Pether Jildenstal

Total 1133 results

Pether Jildenstal
Göteborg University

Recruiting

Monitoring Postoperative Patient-controlled Analgesia (PCA)

Postoperative Pain | Surgery | Nurse-Patient Relations | Patient Controlled Analgesia

Sweden
Peter G Mavrelis

Completed

GERD Treatment With Transoral Incisionless Fundoplication (TIF) Following Hiatal Hernia Surgery (GERD)

Gastro Esophageal Reflux

United States
Peter Brehm GmbH

Terminated

Prospective Post Market Clinical Follow-Up of the Primary Knee Endoprosthesis BPK-S Integration

Osteoarthritis, Knee | Joint Instability

Austria
Anguria, Peter, M.D.

Completed

Determinants of Pterygium Occurrence and Recurrence in a Rural African Population

Pterygium

South Africa
2gether

Unknown

The Effect of Shared Listening to Personalized Music on Symptoms of Behavioral Disorders in the Elderly With Advanced Dementia

Dementia
Peter Hovind

Not yet recruiting

Assessing Repeatability and Intra-individual Variability in [O15]H2O-PET Myocardial Perfusion Imaging (Heart-Wave)

Myocardial Blood Flow

Denmark
Peter Gillgren

Completed

Trial of Surgical Excision Margins in Thick Primary Melanoma - 2

Melanoma | Surgery | Treatment Outcome
Peter Kristensen

Recruiting

DIAbetes TEam and Cgm in Managing Hospitalised Patients With Diabetes (DIATEC)

Diabetes Mellitus, Type 2

Denmark
Peter atef

Recruiting

Portal Vein Flow Velocity as a Screening Tool for Oesophageal Varices in Cirrhotic Patients (Portalflow)

Cirrhosis Portal

Egypt
Peter Nymberg

Withdrawn

Equine Assisted Services in Children and Adolescents With Mental Illness (EASiCAM)

Depression | Anorexia Nervosa | Anxiety Disorders | Anxiety | Mental Disorder in Adolescence | Mental Disorders, Child | School Fear

Sweden
Peter Lommer

Completed

The Impact of ROTO Track® in Helping Patients With Diabetes Rotate Their Insulin Injections Better (ROTOone)

Diabetes

Denmark
Peter Studinger

Suspended

Bioimpedance Analysis in Chronic Heart Failure

Heart Failure

Hungary
Peter Moosmann
Kantonsspital Aarau

Completed

Bendamustine and Bortezomib Combination Therapy in Indolent Non-Hodgkin's Lymphoma(NHL)

Lymphoma, Non-Hodgkin
PETHEMA Foundation

Not yet recruiting

Treatment Protocol for Newky Diagnosed Adult Ph Positive ALL (LALPh2022)

Lymphoblastic Leukemia | Adult ALL | Philadelphia-Positive ALL
PETHEMA Foundation

Recruiting

Clinical Trial to Assess the Safety and Tolerability of the Combination of Low-dose Cytarabine or Azacitidine Plus Venetoclax and Quizartinib in Newly Diagnosed AML Patients Aged Equal or More Than 60 Years Old

Leukemia, Myeloid, Acute | De Novo | Age More 60yr

Spain
PETHEMA Foundation

Recruiting

Chemotherapy and Imatinib in Young Adults With Acute Lymphoblastic Leukemia Ph (BCR-ABL) POSITIVE

Acute Lymphoblastic Leukemia Ph Positive

Spain
PETHEMA Foundation

Recruiting

Treatment of Acute Lymphoblastic Leukemia Ph '(BCR / ABL) Positive Patients Aged > 55 Years

Acute Lymphoblastic Leukemia Ph Positive

Spain
PETHEMA Foundation

Active, not recruiting

Carfilzomib, Cyclophosphamide, Dexamethasone in Multiple Myeloma

Multiple Myeloma

Spain
PETHEMA Foundation

Terminated

REALIB-LLA-2017: Idelalisib in Patients With Acute Lymphoblastic Leukemia

Acute Lymphoblastic Leukemia

Spain
PETHEMA Foundation

Completed

Diagnostic Platform to Perform Centralized and Standardized Rapid Molecular Diagnosis by Next Generation Sequencing (NGS) in Patients Diagnosed With Acute Myeloid Leukemia.

Acute Myeloid Leukemia

Spain
PETHEMA Foundation

Completed

Treatment of Relapsed or Refractory Acute Myeloblastic Leukemia

Acute Myeloblastic Leukemia

Spain
PETHEMA Foundation

Terminated

PROCEDYTE: Depocyte® Administration (Liposomal Cytarabine) as Prophylaxis of Neuromeningeal Infiltration in Acute Lymphoblastic Leukemia (2009-009422-92)

Acute Lymphoblastic Leukemia

Spain
PETHEMA Foundation

Completed

LAL-AR-N-2005:Study Treatment for Children High Risk Acute Lymphoblastic Leukemia (LAL-AR-N-2005)

Acute Lymphoblastic Leukemia

Spain
PETHEMA Foundation

Completed

MINIALO-VELCADE2005: A Study of Bortezomib (Velcade) Treated Multiple Myeloma Patients Pre and Post Allogeneic Haematopoietic Progenitor Cell Transplant With no Myeloablative Conditioning (MINIALO-VELCAD)

Multiple Myeloma

Spain
PETHEMA Foundation

Completed

Treatment of Relapsed Promyelocytic Leukemia With Arsenic Trioxide (ATO)

Acute Promyelocytic Leukemia

Spain
PETHEMA Foundation

Terminated

LENA-LMA-5:Lenalidomide in Acute Myeloid Leukemia (AML)

AML

Spain
PETHEMA Foundation

Terminated

A Prospective, Open, Non-randomized Phase I/II Study of Therapeutic Angiogenesis in Diabetic Patients With Critic Ischemia of Lower Limbs While Administering Positive CD133 Mobilized With G-CSF

Diabetic Patients With Critic Ischemia in Lower Limbs Who Are Administered With CD133+ Cells Mobilized by G-CSF

Spain
PETHEMA Foundation

Completed

Depocyte in the Treatment of CNS Relapse in Patients With Lymphoblastic Leucemia or Very Aggressive Lymphoma

Lymphoma | Lymphoblastic Leukemia

Spain
PETHEMA Foundation

Completed

Treatment of Acute Myeloblastic Leukemia in Younger Patients

Acute Myeloblastic Leukemia

Spain
PETHEMA Foundation

Completed

VELCADEXA: Velcade and Dexamethasone in Multiple Myeloma

Multiple Myeloma

Spain
PETHEMA Foundation

Completed

Nebulized Liposomal Amphotericin B Ambisome for Prophylaxis of Invasive Pulmonary Aspergillosis (AMBINEB)

Acute Myeloid Leukemia | Allogeneic Haematopoietic Progenitor Cell Transplant

Spain
PETHEMA Foundation

Recruiting

Study of Elranatamab for Relapsed or Refractory Myeloma in Patients Previously Exposed to Three-drug Classes

Multiple Myeloma in Relapse

Spain
PETHEMA Foundation

Recruiting

Molecular Diagnostic Platform for AML

Acute Myeloid Leukemia (AML)

Spain
PETHEMA Foundation

Recruiting

SELIBORDARA: Selinexor, Bortezomib and Daratumumab in Multiple Myeloma

Refractory Multiple Myeloma

Spain
PETHEMA Foundation

Recruiting

Clinical Guidelines for APL Treatment

APL

Spain
PETHEMA Foundation

Recruiting

PETHEMA LAL-07FRAIL: All Treatment In Fragile Patients Ph' Negative Over 55 Years

Acute Lymphoblastic Leukemia

Spain
Better Therapeutics

Completed

Pivotal Trial of a Digital Therapeutic for the Treatment of Type 2 Diabetes

Type 2 Diabetes

United States
PETHEMA Foundation

Active, not recruiting

Treatment for Elderly Fit Newly Diagnosed Multiple Myeloma Patients Aged Between 65 and 80 Years

Newly Diagnosed Multiple Myeloma

Spain
PETHEMA Foundation

Active, not recruiting

Study to Investigate the Use of Acalabrutinib in the Treatment of Patients With Chronic Lymphocytic Leukemia

Chronic Lymphocytic Leukemia- Binet Staging System

Spain
PETHEMA Foundation

Terminated

PETHEMA-BLIN-01/PET069014 (BLIN-01)

Philadelphia Chromosome-negative or BCR-ABL-negative, CD19-positive ALL

Spain
PETHEMA Foundation

Active, not recruiting

Ponatinib With Chemotherapy for Young Adults Ph Positive Acute Lymphoblastic Leukemia (PONALFIL)

ALL

Spain
PETHEMA Foundation

Completed

Retrospective Viability Study of the PETHEMA-POMCIDEX Clinical Practice Guidelines for the Treatment of Patients With Relapsed and Refractory Multiple Myeloma (RRMM)

Relapsed and Refractory Multiple Myeloma

Spain
PETHEMA Foundation

Completed

VILMA: Therapeutic Results in Acute Mieloblastic Leukemia in Patients Older Than 60 Years

AML

Spain
PETHEMA Foundation

Completed

Treatment of High Risk Adult Acute Lymphoblastic Leukemia (LAL-AR/2003)

Acute Lymphoblastic Leukemia

Spain
PETHEMA Foundation

Completed

Panobinostat in Combination With Idarubicin and Cytarabine in Patients Aged 65 Years or Older With Newly Diagnosed Acute Myeloblastic Leukaemia (AML) (PANOBIDARA)

Acute Myeloblastic Leukaemia

Spain
PETHEMA Foundation

Completed

LAL-BR/2001: Study Treatment to Low Risk ALL

Acute Lymphoblastic Leukemia

Spain
PETHEMA Foundation

Completed

Epidemiologic Registry PETHEMA LMA 2013

AML

Spain
PETHEMA Foundation

Completed

Rituximab Combined With Chemotherapy in Burkitt's Lymphoma

Acute Lymphoblastic Leukemia | Burkitt's Lymphoma

Spain
PETHEMA Foundation

Completed

Treatment of Newly Diagnosed Patients With Acute Promyelocytic Leukemia (PETHEMA LPA 2005)

Acute Promyelocytic Leukemia

Spain, Uruguay, Poland
PETHEMA Foundation

Completed

Velcaflagida in Relapsed or Refractary Acute Myeloid Leukemia

Acute Myeloid Leukemia

Spain

3

Subscribe